Connect Biopharma Holdings Limited Adjustments For Increase Decrease In Deferred Income Other Than Contract Liabilities
Connect Biopharma Holdings Limited (CNTB) reported Adjustments For Increase Decrease In Deferred Income Other Than Contract Liabilities of -$11.00 thousand for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-05.
Discontinued › Income Statement › Other Income
ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities · last filed 2024-09-05
- 2024-06-30: Adjustments For Increase Decrease In Deferred Income Other Than Contract Liabilities 6 month -$11.00K.
- 2023-06-30: Adjustments For Increase Decrease In Deferred Income Other Than Contract Liabilities 6 month -$490.00K.
| Period end | Adjustments For Increase Decrease In Deferred Income Other Than Contract Liabilities 6 month |
|---|---|
| 2024-06-30 | -$11.00K 6-K · filed 2024-09-05 |
| 2023-06-30 | -$490.00K 6-K · filed 2024-09-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |